Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Agomelatine and Sertraline on Major Depressive Disorders in Patients with Chronic Kidney Disease
TCTR20200319005Phase 3Recruiting
- Sponsor
- Phramongkutklao Hospital
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of agomelatine, sertraline in major depressive disorder (MDD), sponsored by Phramongkutklao Hospital. Started Jun 2019; status: recruiting.
02
Drugs
agomelatinesertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on TCTR20200319005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200319005.